October 6, 2025 |
Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

The team will be hosting 5 dynamic satellite symposia at the congress on topics including advances in metastatic breast cancer, personalizing care for prostate cancer, HER2-targeted therapy for gynecologic cancers, and other important topics in oncology. These symposia are designed to engage clinician learners and help them translate the latest data into action through downloadable slides and lively conversation between world-renowned experts. More information on the symposia and links to register are available here.
We invite Congress attendees to stop by the Medscape booth (#1009) in the exhibit hall to connect with the Medscape Oncology team and explore our latest innovations in oncology education, including the launch of the PIONEER Learning Center – PrecIsion Oncology: Navigating EvidEnce for Real-world impact.
“We have very exciting new education in topics like precision oncology that are going to help learners advance their care and reach more patients. We’re looking forward to great meetings and conversations with our oncology colleagues while we’re in Berlin so we can share more about it,” said Zhizhi Fiske
The Medscape team will be attending the congress from 17-20 October.
For more information on Medscape Oncology education, please contact Zhizhi Fiske
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
This year’s winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to…
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance…
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS…
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right…
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),…
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),…
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer…
Highlights from the Medscape Education full panel discussion during this year’s #ESMO22.
On 11th September, the Medscape team came together at the Eiffel Tower for an exciting event attended by expert faculty, patient advocates and more than a hundred supporters of our…
This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data…
